Pharmacoepidemiologic Study of the Complementary and Alternative Medicine (CAM) Use in Patient with Cancer in Benghazi, Libya

  • Aisha M. Alfituri Libyan International Medical University, Faculty of Pharmacy, PharmD, Benghazi, Libya
  • Faiza A. Elhamdy University of Benghazi, Faculty of Medicine, Department of Physiology, Benghazi, Libya
  • Nour Alagory Libyan International Medical University, Faculty of Pharmacy, PharmD, Benghazi, Libya
  • Almonther Rizq Ateeq Libyan International Medical University, Faculty of Pharmacy, PharmD, Benghazi, Libya
  • Almoatasim Bellh Mustafa Libyan International Medical University, Faculty of Pharmacy, PharmD, Benghazi, Libya
Keywords: Complementary and alternative medicine (CAM), Cancer, Benghazi, Adult, pharmacoepidemiologic survey

Abstract

Background: Cancer patients are increasingly turning to complementary and alternative medicine (CAM) to improve their physical and psychological well-being. This study aimed to explore the prevalence of complementary and alternative medicine (CAM) use by Libyan populations in Benghazi city.

Methods: This cross-sectional survey was conducted among 100 patients attending the National Cancer Center at Howari Hospital in Benghazi city. A 16-item questionnaire was used to collect the data. The questionnaire addressed the sociodemographic characteristics, cancer conditions, and use of CAM. The main outcome of interest was “use of any CAM therapy since cancer diagnosis.”

Results:  The total prevalence of CAM among cancer patients was 100%, regardless of cancer type. Lung and breast cancer were the most prevalent in our study (23 and 22%), with stage 2 being the most common cancer (47%). Prayer was the most widely used CAM modality among study participants (100%). Our data also showed that males had a higher number (57%), and the age group 40-59 was the most common. The highest percentage of participants had a diploma or bachelor degree (54%). Similarly, those living in the city had the highest rates (69%). As well, our results revealed that the most prevalent reason for using CAM was to improve sleep and reduce pain (68%).

Conclusions: This study revealed a prevalent CAM use among cancer patients in the city of Benghazi. It is necessary to promote a patient-centered approach to CAM use.

Downloads

Download data is not yet available.

References

Tabish SA. Complementary and Alternative Healthcare: Is it Evidence-based? Int J Health Sci (Qassim). 2008 Jan;2(1): V-IX. PMID: 21475465; PMCID: PMC3068720.
National Cancer Institute. "Complementary and alternative medicine." Accessed September/11/2012. https://cam.cancer.gov/health_information/categories_of_cam_therapies.htm
Bahall M. Prevalence, patterns, and perceived value of complementary and alternative medicine among cancer patients: a cross-sectional, descriptive study. BMC Complement Altern Med. 2017 Jun 30;17(1):345. doi: 10.1186/s12906-017-1853-6. PMID: 28666435; PMCID: PMC5493839.
Singh P, Chaturvedi A. Complementary and alternative medicine in cancer pain management: a systematic review. Indian J Palliat Care. 2015 Jan-Apr;21(1):105-15. doi: 10.4103/0973-1075.150202. PMID: 25709198; PMCID: PMC4332115
Harris PE, Cooper KL, Relton C, Thomas KJ. Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and update. Int J Clin Pract. 2012;66(10):924–39. [24].
Pokladnikova J, Selke-Krulichova I. Prevalence of complementary and alternative medicine use in the general population in the Czech Republic. Forsch Komplementmed. 2016;23(1):22–8. https://doi.org/10.1159/000443712 Epub 2016 Jan 29.
de Moraes Mello Boccolini, P., Siqueira Boccolini, C. Prevalence of complementary and alternative medicine (CAM) use in Brazil. BMC Complement Med Ther 20, 51 (2020). https://doi.org/10.1186/s12906-020-2842-8
Ali-Shtayeh, M. S., Jamous, R. M., Salameh, N. M. Y., Jamous, R. M., & Hamadeh, A. M. A. (2016). Complementary and alternative medicine use among cancer patients in Palestine with special reference to safety-related concerns. Journal of Ethnopharmacology, 187, 104–122. https://doi.org/https://doi.org/10.1016/j.jep.2016.04.038
Sanford NN, Sher DJ, Ahn C, Aizer AA, Mahal BA. Prevalence and Nondisclosure of Complementary and Alternative Medicine Use in Patients With Cancer and Cancer Survivors in the United States. JAMA Oncol. 2019;5(5):735–737. doi:10.1001/jamaoncol.2019.0349
Molassiotis A, Fernadez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol. 2005;16:655–663. doi: 10.1093/annonc/mdi110. [PubMed] [CrossRef] [Google Scholar] [Ref list]
Bahall M. Prevalence, patterns, and perceived value of complementary and alternative medicine among cancer patients: a cross-sectional, descriptive study. BMC Complementary and Alternative Medicine. 2017;17(1). doi:https://doi.org/10.1186/s12906-017-1853-6
Dehghan M, Mahla Mohebi Rad, Leyla Ahmadi Lari, Behnam Ghorbani-nejad, Milad Mohebi-Rad. The relationship between use of complementary and alternative medicine and health literacy in chronically ill outpatient cases: a cross-sectional study in southeastern Iran. 2023;11. doi:https://doi.org/10.3389/fpubh.2023.988388
Kucukoner M, Bilge Z, Isıkdogan A, Kaplan MA, Inal A, Urakci Z. Complementary and Alternative Medicine Usage in Cancer Patients in Southeast of Turkey. African Journal of Traditional, Complementary, and Alternative Medicines. 2012;10(1):21-25. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3746353/
Published
2024-04-06
How to Cite
M. Alfituri, A., A. Elhamdy, F., Alagory, N., Rizq Ateeq, A., & Bellh Mustafa, A. (2024). Pharmacoepidemiologic Study of the Complementary and Alternative Medicine (CAM) Use in Patient with Cancer in Benghazi, Libya. GPH-International Journal of Biological & Medicine Science, 7(03), 24-34. https://doi.org/10.5281/zenodo.10936482